Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki co
| Current Price | ₹1,876.90 |
|---|---|
| Market Cap | ₹5,139 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 172.2 |
| Return on Equity | 3.58% |
| 52-Week Range | ₹966.70 – ₹1,960.30 |
| Beta (1Y) | 1.16 |
| Dividend Yield | 0.05% |
1. Manufacturing of Speciality Chemicals-100%
Neogen Chemicals Limited (Neogen) is trading at ₹1,876.90, with a market capitalisation of ₹5,139 Cr.
Neogen Chemicals Limited (Neogen) operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Neogen Chemicals Limited (Neogen) has a P/E of 172.2 and a return on equity of 3.58%.